v3.24.3
Common Stock (Tables)
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Activities for the Restricted Stock Issued to Employees
The activities for the restricted stock issued to employees was as follows (in thousands, except per share data):
Number of
Shares		Weighted-
Average
Grant Date
Fair Value Per Share
Unvested restricted stock as of December 31, 2023285 
Granted— $— 
Vested(140)$76.91 
Forfeited— $— 
Unvested restricted stock as of September 30, 2024145 
Schedule of Activity under the 2014 and 2020 Plans
A summary of stock option activity under the 2014 Equity Incentive Plan, 2020 Equity Incentive Plan, and 2022 Inducement Equity Incentive Plan was as follows (in millions, except share amounts which are reflected in thousands, and per share data):
Options Outstanding
Shares
subject to
Options
Outstanding		Weighted-
Average
Exercise
Price Per Share		Weighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate
Intrinsic
Value
Balance as of December 31, 20239,022 $4.38 3.41$853 
Granted— $— 
Exercised(3,316)$2.05 $388 
Cancelled and forfeited(2)$2.31 
Balance as of September 30, 20245,704 $5.73 3.45$781 
Exercisable as of September 30, 20245,452 $5.81 3.51$746 
Vested and expected to vest as of September 30, 20245,704 $5.73 3.45$781 
Summary of RSU Activity
A summary of RSU activity was as follows (in millions, except share amounts which are reflected in thousands, and per share data):
Number of
Shares		Weighted-
Average
Grant Date
Fair Value Per Share		Aggregate
Intrinsic
Value
Unvested RSUs as of December 31, 202337,792 $3,645 
Granted7,492 $123.47 
Vested(14)$79.36 
Vested and settled(10,736)$83.32 
Forfeited(2,269)$82.78 
Unvested RSUs as of September 30, 202432,265 $4,605 
Schedule of Stock-based compensation Expense
The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2023202420232024
Cost of revenue, exclusive of depreciation and amortization$36 $36 $103 $109 
Sales and marketing30 30 90 87 
Research and development119 126 350 379 
General and administrative93 82 276 253 
Total stock-based compensation expense$278 $274 $819 $828